Figure 3A — Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer

Navigate

Research Paper|Volume 8, Issue 12|pp. 3520–3534

Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer

Back to articleFigure 3A(3 of 11)

100%

Figure 3A.The combination therapy enhanced the proliferation inhibition of HUVECs cells in vitro.

Figure 3A — Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer | Aging